These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29215401)

  • 1. Relaxivity of Ferumoxytol at 1.5 T and 3.0 T.
    Knobloch G; Colgan T; Wiens CN; Wang X; Schubert T; Hernando D; Sharma SD; Reeder SB
    Invest Radiol; 2018 May; 53(5):257-263. PubMed ID: 29215401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ferumoxytol-based cerebral blood volume estimates using quantitative R
    Rivera-Rivera LA; Schubert T; Knobloch G; Turski PA; Wieben O; Reeder SB; Johnson KM
    Magn Reson Med; 2018 Jun; 79(6):3072-3081. PubMed ID: 29096054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Three Ultrasmall, Superparamagnetic Iron Oxide Nanoparticles for MRI at 3.0 T.
    Colbert CM; Ming Z; Pogosyan A; Finn JP; Nguyen KL
    J Magn Reson Imaging; 2023 Jun; 57(6):1819-1829. PubMed ID: 36250695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla.
    Pintaske J; Martirosian P; Graf H; Erb G; Lodemann KP; Claussen CD; Schick F
    Invest Radiol; 2006 Mar; 41(3):213-21. PubMed ID: 16481903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of Ferumoxytol in the Abdomen and Pelvis: A Dosing Study with 1.5- and 3.0-T MRI Relaxometry.
    Wells SA; Schubert T; Motosugi U; Sharma SD; Campo CA; Kinner S; Woo KM; Hernando D; Reeder SB
    Radiology; 2020 Jan; 294(1):108-116. PubMed ID: 31714191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain iron deposition after Ferumoxytol-enhanced MRI: A study of Porcine Brains.
    Theruvath AJ; Aghighi M; Iv M; Nejadnik H; Lavezo J; Pisani LJ; Daldrup-Link HE
    Nanotheranostics; 2020; 4(4):195-200. PubMed ID: 32637297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal study of R2* and R2 magnetic resonance imaging relaxation rate measurements in murine liver after a single administration of 3 different iron oxide-based contrast agents.
    Kalber TL; Smith CJ; Howe FA; Griffiths JR; Ryan AJ; Waterton JC; Robinson SP
    Invest Radiol; 2005 Dec; 40(12):784-91. PubMed ID: 16304482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protein and contrast agent-specific influence of pathological plasma-protein concentration levels on contrast-enhanced magnetic resonance imaging.
    Goetschi S; Froehlich JM; Chuck NC; Curcio R; Runge VM; Andreisek G; Nanz D; Boss A
    Invest Radiol; 2014 Sep; 49(9):608-19. PubMed ID: 24710201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
    Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M
    Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular MRI with ferumoxytol.
    Finn JP; Nguyen KL; Han F; Zhou Z; Salusky I; Ayad I; Hu P
    Clin Radiol; 2016 Aug; 71(8):796-806. PubMed ID: 27221526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative ferumoxytol-enhanced MRI in pregnancy: A feasibility study in the nonhuman primate.
    Zhu A; Reeder SB; Johnson KM; Nguyen SM; Fain SB; Bird IM; Golos TG; Wieben O; Shah DM; Hernando D
    Magn Reson Imaging; 2020 Jan; 65():100-108. PubMed ID: 31655139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Iron Assessment after Ferumoxytol-enhanced MRI in Children and Young Adults with Arteriovenous Malformations: A Case-Control Study.
    Iv M; Ng NN; Nair S; Zhang Y; Lavezo J; Cheshier SH; Holdsworth SJ; Moseley ME; Rosenberg J; Grant GA; Yeom KW
    Radiology; 2020 Nov; 297(2):438-446. PubMed ID: 32930651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro T2 relaxivities of the Gd-based contrast agents (GBCAs) in human blood at 1.5 and 3 T.
    Shen Y; Goerner FL; Heverhagen JT; Snyder C; Hu D; Li X; Runge VM
    Acta Radiol; 2019 Jun; 60(6):694-701. PubMed ID: 30205704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T.
    Shen Y; Goerner FL; Snyder C; Morelli JN; Hao D; Hu D; Li X; Runge VM
    Invest Radiol; 2015 May; 50(5):330-8. PubMed ID: 25658049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Tumor Necrosis with Ferumoxytol.
    Aghighi M; Golovko D; Ansari C; Marina NM; Pisani L; Kurlander L; Klenk C; Bhaumik S; Wendland M; Daldrup-Link HE
    PLoS One; 2015; 10(11):e0142665. PubMed ID: 26569397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical and Pharmacokinetic Profiles of Gadopiclenol: A New Macrocyclic Gadolinium Chelate With High T1 Relaxivity.
    Robic C; Port M; Rousseaux O; Louguet S; Fretellier N; Catoen S; Factor C; Le Greneur S; Medina C; Bourrinet P; Raynal I; Idée JM; Corot C
    Invest Radiol; 2019 Aug; 54(8):475-484. PubMed ID: 30973459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium-based magnetic resonance contrast agents at 7 Tesla: in vitro T1 relaxivities in human blood plasma.
    Noebauer-Huhmann IM; Szomolanyi P; Juras V; Kraff O; Ladd ME; Trattnig S
    Invest Radiol; 2010 Sep; 45(9):554-8. PubMed ID: 20697225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging behavior of the normal adrenal on ferumoxytol-enhanced MRI: preliminary findings.
    Gunn AJ; Seethamraju RT; Hedgire S; Elmi A; Daniels GH; Harisinghani MG
    AJR Am J Roentgenol; 2013 Jul; 201(1):117-21. PubMed ID: 23789664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.
    Toth GB; Varallyay CG; Horvath A; Bashir MR; Choyke PL; Daldrup-Link HE; Dosa E; Finn JP; Gahramanov S; Harisinghani M; Macdougall I; Neuwelt A; Vasanawala SS; Ambady P; Barajas R; Cetas JS; Ciporen J; DeLoughery TJ; Doolittle ND; Fu R; Grinstead J; Guimaraes AR; Hamilton BE; Li X; McConnell HL; Muldoon LL; Nesbit G; Netto JP; Petterson D; Rooney WD; Schwartz D; Szidonya L; Neuwelt EA
    Kidney Int; 2017 Jul; 92(1):47-66. PubMed ID: 28434822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study.
    Iv M; Samghabadi P; Holdsworth S; Gentles A; Rezaii P; Harsh G; Li G; Thomas R; Moseley M; Daldrup-Link HE; Vogel H; Wintermark M; Cheshier S; Yeom KW
    Radiology; 2019 Jan; 290(1):198-206. PubMed ID: 30398435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.